|
regulation of inositol biosynthetic process
|
GO_1900088 |
[Any process that modulates the frequency, rate or extent of inositol biosynthetic process.] |
|
negative regulation of inositol biosynthetic process
|
GO_1900089 |
[Any process that stops, prevents or reduces the frequency, rate or extent of inositol biosynthetic process.] |
|
positive regulation of inositol biosynthetic process
|
GO_1900090 |
[Any process that activates or increases the frequency, rate or extent of inositol biosynthetic process.] |
|
regulation of raffinose biosynthetic process
|
GO_1900091 |
[Any process that modulates the frequency, rate or extent of raffinose biosynthetic process.] |
|
negative regulation of raffinose biosynthetic process
|
GO_1900092 |
[Any process that stops, prevents or reduces the frequency, rate or extent of raffinose biosynthetic process.] |
|
positive regulation of raffinose biosynthetic process
|
GO_1900093 |
[Any process that activates or increases the frequency, rate or extent of raffinose biosynthetic process.] |
|
obsolete regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry
|
GO_1900094 |
[OBSOLETE. Any regulation of transcription from RNA polymerase II promoter that is involved in determination of left/right symmetry.] |
|
obsolete regulation of dosage compensation by inactivation of X chromosome
|
GO_1900095 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of dosage compensation, by inactivation of X chromosome.] |
|
obsolete negative regulation of dosage compensation by inactivation of X chromosome
|
GO_1900096 |
[OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of dosage compensation, by inactivation of X chromosome.] |
|
obsolete positive regulation of dosage compensation by inactivation of X chromosome
|
GO_1900097 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of dosage compensation, by inactivation of X chromosome.] |
|
cumulus cell differentiation
|
GO_0001549 |
[The process in which a subpopulation of granulosa cells surrounding the oocyte acquires the specialized features of an ovarian cumulus cell.] |
|
antral ovarian follicle growth
|
GO_0001547 |
[Increase in size of antral follicles due to cell proliferation and/or growth of the antral cavity.] |
|
follicular fluid formation in ovarian follicle antrum
|
GO_0001548 |
[The menstrual cycle process that results in the formation of one central cavity separating the oocyte/cumulus complex from mural granulosa and theca cells during the various stages of oogenesis.] |
|
preantral ovarian follicle growth
|
GO_0001546 |
[Increase in size of follicles surrounded by two or more layers of granulosa cells up to the onset of antrum formation.] |
|
ovarian follicle rupture
|
GO_0001543 |
[Disruption of theca cell layer releasing follicular fluid and/or the oocyte.] |
|
initiation of primordial ovarian follicle growth
|
GO_0001544 |
[Increase in size of primordial follicles including proliferation and shape changes of granulosa and/or theca cells until oocyte is surrounded by one layer of cuboidal shaped granulosa cells (primary follicle).] |
|
ovarian follicle development
|
GO_0001541 |
[The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.] |
|
ovulation from ovarian follicle
|
GO_0001542 |
[The process leading to the rupture of the follicle, releasing the centrally located oocyte into the oviduct. An example of this is found in Mus musculus.] |
|
ovulation
|
GO_0030728 |
[The release of a mature ovum/oocyte from an ovary.] |
|
amyloid-beta binding
|
GO_0001540 |
[Binding to an amyloid-beta peptide/protein.] |